| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |